22-19183540-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007098.4(CLTCL1):āc.4677G>Cā(p.Glu1559Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000155 in 1,613,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007098.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLTCL1 | NM_007098.4 | c.4677G>C | p.Glu1559Asp | missense_variant | 30/33 | ENST00000427926.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLTCL1 | ENST00000427926.6 | c.4677G>C | p.Glu1559Asp | missense_variant | 30/33 | 1 | NM_007098.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000883 AC: 22AN: 249044Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135150
GnomAD4 exome AF: 0.000160 AC: 234AN: 1461470Hom.: 0 Cov.: 31 AF XY: 0.000172 AC XY: 125AN XY: 727016
GnomAD4 genome AF: 0.000105 AC: 16AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2022 | The c.4677G>C (p.E1559D) alteration is located in exon 30 (coding exon 30) of the CLTCL1 gene. This alteration results from a G to C substitution at nucleotide position 4677, causing the glutamic acid (E) at amino acid position 1559 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at